BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30842146)

  • 1. Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy.
    Hao F; Dong S; Yang C; Li Z; Cheng Z; Zhong L; Teng L; Meng Q; Lu J; Wu F; Xie J; Teng L; Lee RJ
    Anticancer Res; 2019 Mar; 39(3):1169-1178. PubMed ID: 30842146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
    Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
    Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly antibacterial polymeric hybrid micelle with efficiently targeted anticancer siRNA delivery and anti-infection in vitro/in vivo.
    Zhou L; Xi Y; Chen M; Niu W; Wang M; Ma PX; Lei B
    Nanoscale; 2018 Sep; 10(36):17304-17317. PubMed ID: 30198034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
    Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
    Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
    Huang HY; Kuo WT; Chou MJ; Huang YY
    J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery.
    Wang W; Balk M; Deng Z; Wischke C; Gossen M; Behl M; Ma N; Lendlein A
    J Control Release; 2016 Nov; 242():71-79. PubMed ID: 27498020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery.
    Zhao ZX; Gao SY; Wang JC; Chen CJ; Zhao EY; Hou WJ; Feng Q; Gao LY; Liu XY; Zhang LR; Zhang Q
    Biomaterials; 2012 Oct; 33(28):6793-807. PubMed ID: 22721724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.
    Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y
    Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2008 Jul; 129(2):107-16. PubMed ID: 18486981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
    Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed Micelles.
    Hao F; Lee RJ; Yang C; Zhong L; Sun Y; Dong S; Cheng Z; Teng L; Meng Q; Lu J; Xie J; Teng L
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30795589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome.
    Kang L; Fan B; Sun P; Huang W; Jin M; Wang Q; Gao Z
    Acta Biomater; 2016 Oct; 44():341-54. PubMed ID: 27545812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.